iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022
Rhea-AI Summary
iCAD, Inc. (NASDAQ: ICAD) announced it will release its third-quarter financial results for the period ending September 30, 2022, after market close on November 10, 2022. A conference call is scheduled for 4:30 PM ET on the same day, allowing investors and analysts to discuss the outcomes. The information aims to provide insights into the company's ongoing efforts in cancer detection and therapy solutions, reflecting its position as a leader in medical technology.
Positive
- Scheduled release of financial results may indicate transparency and ongoing business operations.
Negative
- None.
News Market Reaction – ICAD
In the trading session that priced this news, ICAD gained 2.65%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on November 10, 2022.
| Conference Call | ||
| Thursday, November 10, 2022 at 4:30 PM ET | ||
| Domestic: | 888-506-0062 | |
| International: | 973-528-0011 | |
| Conference ID: | 393244 | |
| Webcast: | https://www.webcaster4.com/Webcast/Page/2879/46603 | |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
